From: The risk factors associated with COVID-19-Related death among patients with end‐stage renal disease
Characteristics | Survivors N = 46 | Non-Survivors N = 28 | P-value |
---|---|---|---|
Age (year), Mean (SD) | 59.1 (15.3) | 70.1 (12.4) | 0.002 |
Age ≥ 65 years, % (N) | 39.1% (18) | 75% (21) | 0.004 |
Gender Male, % (N) | 60.9% (28) | 82.1% (23) | 0.072 |
Receiving invasive mechanical ventilation on admission% (N) | 2.2% (1) | 71.4% (20) | < 0.001 |
O2 saturation < 93% % (N) | 41.3% (19) | 82.1% (23) | 0.001 |
Lack of consciousness | 7.7% (4) | 30.4% (8) | 0.030 |
Comorbidities | |||
HTN | 54.3% (25) | 57.1% (16) | 1.00 |
DM | 41.3% (19) | 57.1% (16) | 0.233 |
CVD | 26.1% (12) | 35.7% (10) | 0.437 |
Other comorbiditiesa | 13.0% (6) | 7.1% (2) | 0.702 |
Laboratory findings (Median (IQR)) | |||
WBC count, × 109 per L, | 9.4 (6.5–14) | 9.6 (5.7–13.8) | 0.735 |
Lymphocyte count,× 109/L | 1.80 (1.00-2.50) | 1.20 (0.67–2.20) | 0.049 |
Neutrophils, ×109/L | 7.5 (6.9–8.5) | 8.5 (7.8-9.0) | 0.015 |
AST, U/L | 29.0 (20.6–39.0) | 44.0 (28.5–68.3) | 0.042 |
ALT, U/L | 22.0 (15.5–37.0) | 31.2 (23.7–37.0) | 0.349 |
Creatinine, mg/dl | 6.9 (4.8–9.1) | 5.5 (4.3–7.6) | 0.109 |
Hb, g/dL | 10.7 (8.6–13.4) | 12.3 (10.1–13.8) | 0.190 |
RBC, million/mm3 | 3.8 (3.1–4.4) | 3.9 (3.2–4.8) | 0.919 |
MCV, fl. | 87.9 (82.5–97.9) | 86.6 (83.1–98.7) | 1.00 |
MCH, pg | 29.0 (27.3–31.0) | 28.0 (26.8–32.1) | 0.756 |
Platelet counts, ×103/Ml | 181.0 (125.5–248.0) | 192.0 (163.5-236.5) | 1.00 |
LDH, U/L | 441.5 (342.5-591.7) | 571.0 (410.0 -798.0) | 0.695 |
ESR, mm/h | 54.0(35.0–70.0) | 48.0 (24.7–83.0) | 0.867 |
CRP, mg/l | 23.5 (3.0–75.0) | 32.6 (15.0–79.0) | 0.484 |
CPKk, U/L | 68.5 (46.5-134.5) | 136.0 (45.0-287.7) | 0.372 |
Urea, | 105.0 (92.0-183.0) | 106.0 (24.0-157.0) | 1.00 |
Sodium (Na), mmol/L | 135.0 (128.8-137.5) | 133.0 (130.0-142.5) | 0.804 |
Potassium (K), mmol/L | 5.1 (4.5–5.4) | 4.8 (4.2–5.2) | 0.134 |
PT, S | 14.0 (13.5–16.2) | 14.0 (13.5–15.5) | 0.804 |